Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses

被引:96
|
作者
Chambers, CA [1 ]
Kuhns, MS [1 ]
Allison, JP [1 ]
机构
[1] Univ Calif Berkeley, Howard Hughes Med Res Inst, Canc Res Lab, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA
关键词
CD152; inhibitory costimulation; homeostasis; tolerance;
D O I
10.1073/pnas.96.15.8603
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CTLA-4-deficient mice develop a fatal lymphoproliferative disorder, characterized by polyclonal expansion of peripheral lymphocytes. To examine the effect of restricting the CD4(+) TCR repertoire on the phenotype of CTLA-4-deficient mice and to assess the influence of CTLA-4 on peptide-specific CD4(+) T cell responses in vitro, an MHC class II-restricted T cell receptor (AND TCR) transgene was introduced into the CTLA-4(-/-) animals. The expression of the AND TCR transgene by CD4(+) T cells delays but does not prevent the lymphoproliferation in the CTLA-4(-/-) mice. The CD4(+) T cells become preferentially activated and expand. Interestingly, young AND TCR+ CTLA-4(-/-) mice carrying a null mutation in the rag-1 gene remain healthy and the T cells maintain a naive phenotype until later in life. We demonstrate that CTLA-4 regulates the peptide-specific proliferative response generated by naive and previously activated AND TCR+ RAG(-/-) T cells in vitro. The absence of CTLA-4 also augments the responder frequency of cytokine-secreting AND TCR+ RAG(-/-) T cells. These results demonstrate that CTLA-4 is a keg regulator of peptide specific CD4(+) T cell responses and support the model that CTLA-4 plays a differential role in maintaining T cell homeostasis of CD4(+) vs. CD8(+) T cells.
引用
收藏
页码:8603 / 8608
页数:6
相关论文
共 50 条
  • [1] Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells
    Kuhns, MS
    Epshteyn, V
    Sobel, RA
    Allison, LP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) : 12711 - 12716
  • [2] Cytotoxic T lymphocyte antigen-4 (CTLA-4) as a therapeutic Target in Tumor immunotherapy
    Jaeger, D.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 : S9 - S10
  • [3] Influence of cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in periodontitis
    Houshmand, B.
    Rafiei, A.
    Hajilooi, M.
    ARCHIVES OF ORAL BIOLOGY, 2012, 57 (09) : 1218 - 1224
  • [4] The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology
    Sansom, David M.
    Walker, Lucy S. K.
    IMMUNOLOGICAL REVIEWS, 2006, 212 : 131 - 148
  • [5] Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) engagement has a long lasting effect on subsequent T cell responses
    Engelhardt, JJ
    Kuhns, M
    Sullivan, T
    Allison, JP
    FASEB JOURNAL, 2002, 16 (04): : A711 - A711
  • [6] Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behcet's disease
    Duzgun, N.
    Duman, T.
    Keskin, O.
    Morris, Y.
    Tutkak, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S100 - S100
  • [7] Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
    Kim, Gil-Ran
    Choi, Je-Min
    MOLECULES AND CELLS, 2022, 45 (08) : 513 - 521
  • [8] CYTOTOXIC T-LYMPHOCYTE ANTIGEN-4 (CTLA-4) EXPRESSED IN HUMAN MESENCHYMAL STROMAL CELLS
    Schoenbeck, K.
    Tran, C. L.
    Strehl, C.
    Gaber, T.
    Jakstadt, M.
    Roehner, E.
    Burmester, G. R.
    Buttgereit, F.
    Hoff, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 794 - 794
  • [9] Cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in early rheumatoid arthritis
    Young-Min, S.
    Pearce, S. H. S.
    Charlton, S.
    Marshall, N.
    Rowan, A. D.
    Griffiths, I. D.
    Kendall-Taylor, P.
    Cawston, T. E.
    Vaidya, B.
    RHEUMATOLOGY, 2001, 40 : 16 - 16
  • [10] Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer
    Thompson, R. Houston
    Allison, James P.
    Kwon, Eugene D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 442 - 447